Efficacy of 3,4-Diaminopyridine and Pyridostigmine in the Treatment of Lambert–Eaton Myasthenic Syndrome: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study-Reference-Cited by-同舟云学术

Efficacy of 3,4-Diaminopyridine and Pyridostigmine in the Treatment of Lambert–Eaton Myasthenic Syndrome: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Published:2009-04-08 Issue:1 Volume:86 Page:44-48
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:
Short-container-title:Clin Pharmacol Ther

Author:

Wirtz PW,Verschuuren JJ,van Dijk JG,de Kam ML,Schoemaker RC,van Hasselt JGC,Titulaer MJ,Tjaden UR,den Hartigh J,van Gerven JMA

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference15 articles.

1. 3,4-Diaminopyridine in the Treatment of Lambert–Eaton Myasthenic Syndrome

2. A randomized trial of 3,4-diaminopyridine in Lambert-Eaton myasthenic syndrome

3. Pharmacokinetics and oral bioavailability of pyridostigmine in man

4. The relationship of plasma levels of pyridostigmine to clinical effect in patients with myasthenia gravis

5. Quantitative correlation between plasma pyridostigrnine levels and neuromuscular function in myasthenia gravis

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Foodborne botulism outbreak with potential new management options;Saudi Medical Journal;2024-06

2. Amifampridines are the Most Effective Drugs for Treating Lambert-Eaton Myasthenic Syndrome With a Focus on Pediatric Lambert-Eaton Myasthenic Syndrome;Journal of Clinical Neurology;2024

3. Lambert-Eaton myasthenic syndrome;Handbook of Clinical Neurology;2024

4. Clinical, Pathophysiological and Electrodiagnostic Aspects of Lambert-Eaton Myasthenic Syndrome;Topics in Autonomic Nervous System;2023-11-02

5. Simulations of active zone structure and function at mammalian NMJs predict that loss of calcium channels alone is not sufficient to replicate LEMS effects;Journal of Neurophysiology;2023-05-01